title: Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease.
authors.affiliation: Department of Molecular and Clinical Endocrinology, Federico II University of Naples, Italy. colao@unina.it
authors.forename: A
authors.initials: A
authors.lastname: Colao
authors.forename: R
authors.initials: R
authors.lastname: Pivonello
authors.forename: S
authors.initials: S
authors.lastname: Lastoria
authors.forename: A
authors.initials: A
authors.lastname: Faggiano
authors.forename: D
authors.initials: D
authors.lastname: Ferone
authors.forename: G
authors.initials: G
authors.lastname: Lombardi
authors.forename: G
authors.initials: G
authors.lastname: Fenzi
mesh_terms: D006111:Graves Disease / Q000000981:diagnostic imaging* / Q000503:physiopathology; D006801:Humans; D007205:Indium Radioisotopes; D015282:Octreotide / Q000031:analogs & derivatives; D004369:Pentetic Acid / Q000031:analogs & derivatives; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin / Q000032:analysis*; D013004:Somatostatin / Q000031:analogs & derivatives; D013725:Terbium
chemical_list: D007205:Indium Radioisotopes; D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin; D013725:Terbium; C071632:SDZ 215-811; D013004:Somatostatin; D004369:Pentetic Acid; D015282:Octreotide